Tenaya Therapeutics, Inc. (TNYA)
0.7443
-0.03
(-3.34%)
USD |
NASDAQ |
Apr 16, 13:48
Tenaya Therapeutics Research and Development Expense (Quarterly) : 14.80M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 2.141M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Savara, Inc. | 20.90M |
| Vericel Corp. | 7.253M |
| BioMarin Pharmaceutical, Inc. | 192.41M |